1369 related articles for article (PubMed ID: 19667161)
1. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
3. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
4. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
5. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
7. Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
Achanzar WE; Moyer CF; Marthaler LT; Gullo R; Chen SJ; French MH; Watson LM; Rhodes JW; Kozlosky JC; White MR; Foster WR; Burgun JJ; Car BD; Cosma GN; Dominick MA
Toxicol Appl Pharmacol; 2007 Sep; 223(3):246-56. PubMed ID: 17663016
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets?
Sertznig P; Seifert M; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):383-6. PubMed ID: 20214982
[TBL] [Abstract][Full Text] [Related]
9. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
11. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
[TBL] [Abstract][Full Text] [Related]
12. PPAR gamma is an important transcription factor in 1 alpha,25-dihydroxyvitamin D3-induced involucrin expression.
Dai X; Sayama K; Shirakata Y; Tokumaru S; Yang L; Tohyama M; Hirakawa S; Hanakawa Y; Hashimoto K
J Dermatol Sci; 2008 Apr; 50(1):53-60. PubMed ID: 18077140
[TBL] [Abstract][Full Text] [Related]
13. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
14. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
16. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
17. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
19. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
20. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
Hosoi J; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
